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Abstract 
 
Background: A younger age at onset of use of a specific substance is a well-documented risk-
factor for a substance use disorder (SUD) related to that specific substance. However, the 
cross-substance relationship between a younger age at onset of alcohol use (AU) and nicotine 
use (NU) and the risk of cannabis use disorders (CUD) in adolescence and early adulthood 
remains unclear. 
Aims: To identify the sequence of and latency between initial AU/NU and initial cannabis use 
(CU). To investigate whether younger age at AU- and NU-onset is associated with any and 
earlier CU-onset and a higher risk of transition from first CU to CUD, taking into account 
externalizing disorders (ED) and parental substance use disorders as putative influential 
factors. Methods: Prospective-longitudinal community study with N = 3021 subjects (baseline 
age 14–24) and up to four assessment waves over up to ten years with additional direct 
parental and family history information. Substance use and CUD were assessed with the 
DSM-IV/M-CIDI.  
Results: Most subjects with CU reported AU (99%) and NU (94%). Among users of both 
substances, 93% reported AU prior to CU (87% for NU). After adjustment for ED and 
parental substance use disorders younger age at AU-onset was associated with any CU. 
Younger age at NU-onset was associated with earlier CU initiation. Younger age at AU- and 
NU-onset was not associated with a higher risk of CUD.  
Conclusions: The cross-substance relevance of younger age at first AU and NU for the risk of 
CUD is limited to early CU involvement.   
 
Keywords: Adolescence Epidemiology DSM-IV-cannabis use disorders Etiology Parental 
disorder Family history   
 
 
 
 
 
 
 
 
 
1. Introduction  
 
A younger age at onset of use of a specific substance is a well-documented risk factor for 
substance use disorders (SUD, DSM-IV-substance abuse or dependence) related to this 
specific substance (Behrendt et al., 2009; Breslau et al., 1993; Buchmann et al., 2009; Chen et 
al., 2005; Dawson et al., 2008; DeWit et al., 2000). Nevertheless, there are still restrictions to 
the understanding of the role of younger age at onset of substance use (SU) in substance use 
disorder development. It remains unclear whether younger age at substance use onset is a 
substance-specific risk-factor or a risk factor for substance use disorders across substance 
classes. It is also unclear whether a cross-substance association between a younger age at 
substance use onset and substance use disorders is independent of important influential factors 
that may constitute a general underlying vulnerability for early substance use and SUD. 
Therefore, we investigate the cross-substance relationship between younger age at onset of 
use of one substance for the risk of substance use disorders related to another substance. Here, 
we focus on the role of younger age at onset of alcohol use (AU) and nicotine use (NU) for 
the risk of cannabis use disorders (CUD). This is due to several reasons: at least experimental 
AU and NU are almost normative experiences in adolescence in western societies and most 
likely the first substance use experiences (Poelen et al., 2005; Wittchen et al., 2008; Young et 
al., 2002). Epidemiological evidence indicates that adolescents are unusually naïve to AU and 
NU at first cannabis use (CU) (Bonomo et al., 2004; Everett et al., 1999; Hayatbakhsh et al., 
2007; Kandel and Yamaguchi, 1993; Monshouwer et al., 2005; Palmer et al., 2009; Patton et 
al., 2002; Poelen et al., 2005; Wagner and Anthony, 2002a; Wittchen et al., 2008; Young et 
al., 2002). Cannabis is the most widely used illegal substance in western societies (European 
Monitoring Centre for Drugs and Drug Addiction, 2010; United Nations Office on Drugs and 
Crime, 2010). For a proportion of users CU leads to CUD, considerable psychosocial sequelae 
and treatment need (Coffey et al., 2002; European Monitoring Centre for Drugs and Drug 
Addiction, 2010; Georgiades and Boyle, 2007; Hayatbakhsh et al., 2007; Patton et al., 2002). 
Investigating the relationship between younger age at onset of AU and NU and the risk of 
CUD is important for early identification of youth at risk of CUD and for the planning of 
timely preventive efforts. For this matter, it is also important to investigate the latency 
between first AU/NU and first CU-involvement.  
 
To date, the specific relationship between a younger age at first AU and NU and CUD risk 
remains unclear, despite well-documented general cross-substance associations for any 
substance use and substance use disorders (Grucza and Bierut, 2006; Lynskey et al., 2003; 
Palmer et al., 2009). Such relationships may exist because any AU and NU as well as younger 
age at AU- and NU-onset are associated with the risk of at least experimental CU and younger 
age at CU-onset (Caris et al., 2009; Kokkevi et al., 2006; Sartor et al., 2009; von Sydow et al., 
2002; Wagner and Anthony, 2002b), the latter of which predicts CUD (Chen et al., 2005).  
 
It also remains unclear whether primacy of AU or NU (i.e., which of the two substances was 
tried first) which may indicate a deviant substance use initiation pattern and thus CUD risk 
and prevention need, plays a role in this regard (Degenhardt et al., 2009). Importantly, other 
factors may also play a role in the relationship between younger age at first AU and NU and 
the risk of CUD. It has been proposed that early use of different substances and different 
substance use disorders share underlying influential factors (Morral et al., 2002; Palmer et al., 
2009; Sartor et al., 2009), most importantly externalizing disorders, genetic factors, and 
familial SUD. Externalizing disorders and parental substance use disorders are related to 
offspring substance use disorders and younger age at substance use onset (Elkins et al., 2007; 
King et al., 2004; Lieb et al., 2001, 2002; McGue and Iacono, 2008; Obot et al., 2001). 
However, younger age at first AU is a risk factor for alcohol use disorders independent of 
these factors (Dawson et al., 2008), underlining the possible specific importance of younger 
age at substance use onset (Agrawal et al., 2009). As shown for alcohol, neurodegenerative 
effects of early substance use may lead to reduced behavioral control (Nixon and McClain, 
2010), a factor relevant for all kinds of substance use disorders including CUD (Elkins et al., 
2007; Hayatbakhsh et al., 2008). Therefore, we hypothesize to find a cross-substance 
relationship between younger age at AU- and NU-onset and an elevated CUD risk 
independent of younger age at CU-onset, externalizing disorders and parental SUD. 
Considering these factors can help understanding the role of early AU/NU in CUD etiology 
and identifying the most important indicators of CUD risk.  
 
We investigate in a community sample of adolescents and young adults  
 
(1) the sequence of and latency between AU/NU and CU initiation,  
(2) whether a younger age at AU-onset and younger age at NUonset are associated with a 
higher risk of any CU, younger age at first CU, and CUD,  
(3) whether the association between a younger age at AU-onset and younger age at NU-onset 
and the risk of any CU and younger age at first CU is independent of externalizing disorders, 
parental alcohol dependence and parental illegal substance dependence; whether the 
association between a younger age at AU-onset and younger age at NU-onset and the risk of 
CUD is independent of externalizing disorders, parental alcohol and illegal substance 
dependence and younger age at CU-onset,  
(4) whether results for (2) and (3) differ by primacy of AU or NU.  
 
 
2. Methods  
 
2.1. Study sample and design  
 
The prospective-longitudinal EDSP (Early Developmental Stages of Psychopathology) study 
investigates vulnerabilities and risk-factors of substance use and disorders in a community 
sample of 3021 adolescents and young adults aged 14–24 at study baseline (T0). The study 
includes three follow-up assessments (T1, T2, T3). Detailed information on the study has 
been provided (Beesdo et al., 2007; Lieb et al., 2000; Wittchen et al., 1998b). The baseline 
sample was randomly drawn from government registries in metropolitan Munich, Germany in 
1994. To emphasize early developmental stages, subjects aged 14–15 years were sampled at 
twice the probability and subjects aged 22–24 were sampled at half the probability of those 
aged 16–21 years. Follow-up examinations were carried out approximately 1.6 years (T1, 
median interval since baseline), 3.5 years (T2) and 8.2 years (T3) after T0. At T1, only 
subjects aged 14–17 years at T0 were assessed (N = 1228; response rate 88.0%). 84.3% (N = 
2548) of T0 participants completed T2, 73.2% (N = 2210) T3. The T3-age range was 21–34 
years.  
 
2.2. Diagnostic assessment  
 
At all waves, participants were interviewed with the computer-assisted standardized Munich-
Composite International Diagnostic Interview (DIA-X/M-CIDI) (Wittchen et al., 1998a; 
Wittchen and Pfister, 1997), an updated version of the World Health Organisation (WHO) 
CIDI (Wittchen and Semmler, 1990) (lifetime version at T0; interval version at T1–T3). For 
DSM-IV diagnoses, computerized M-CIDI/DSM-IV algorithms were applied. To help 
respondents, e.g., in answering symptom questions, the DIA-X/M-CIDI includes a 
respondent’s booklet with symptom lists and cognitive aids. Test–retest reliability and validity 
of DIA-X/M-CIDI diagnoses have been established (Lachner et al., 1998; Reed et al., 1998; 
Wittchen et al., 1998a). Externalizing disorder diagnosis was derived from T1 parental reports 
on conduct disorder and T2 participants’ reports on conduct and antisocial personality 
disorder resulting in externalizing disorder-information on 2638 subjects.  
 
2.2.1. Assessment of substance use and disorders. Substance use and disorders were assessed 
with the three DIA-X/M-CIDI-sections on alcohol, nicotine, and medication and illegal 
substances (Wittchen et al., 2008). For CUD assessment minimal CU (>4 times) was required. 
N = 142 subjects who declined answering questions on illegal substances truthfully at one or 
more wave(s) were excluded from all analyses. Substance use (disorder) categories 
considered here were: any AU, NU and CU, and DSM-IV-CUD (cannabis abuse and 
dependence).  
 
Baseline CU in the younger cohort (OR 0.66, 95% CI: 0.4–0.9, p = 0.015) and baseline NU in 
the older cohort (OR 0.71, 95% CI: 0.5–0.9, p = 0.027) predicted attrition at T3.  
 
2.2.2. Parental diagnoses. The EDSP includes a family supplement (Lieb et al., 2000). Parents 
were directly interviewed at T1 and T3 (1056 T1 parent-interviews). Since the primary 
objective of T3 was to investigate first-degree relatives of offspring with a lifetime affective 
disorder, only these relatives were invited (252 subjects with T3 parent-interviews). Directly 
interviewed parents underwent assessment with the DIA-X/M-CIDI. Attempts were made to 
ensure interviewer blindness to offspring diagnostic status.  
 
Family history (FH) information on mental disorders in both parents was obtained from 
offspring (T0, T2, T3). FH-component items were designed using a modified version of the 
Family History- Research Diagnostic Criteria as a model (Merikangas et al., 1998). At T0, 
DIA-X/M-CIDI stem questions and questions to determine whether the relative sought 
professional help because of the symptoms were used. At T2 and T3, a FH-module with fully 
structured sections covering DSM-IV criteria was applied.  
 
Here, parental diagnoses were determined as follows: whenever available, direct information 
from T1 and/or T3 (N = 1152 mothers, N = 211 fathers, N = 1189 any parent) was used. If 
this was impossible, T3 FH-information was used. T2 FH-information was used when direct 
information and T3 FH-information was unavailable. T0 FH-information was used when all 
other information types were unavailable. This algorithm is based on agreement patterns 
between FH and direct interviews (highest agreement at T3). Values were comparable with 
previous FH-reporting (Vandeleur et al., 2008). Direct or FH-information on parental 
substance dependence is available for N = 2720 fathers and N = 2763 mothers of the N = 
3021 adolescent and young adult subjects (T0 FH-information did not permit differentiation 
between substance abuse and dependence and was not used).  
 
2.3. Statistical analysis  
 
To ensure community representativeness, data were weighted to account for different 
sampling probabilities at baseline according to age, and response rates at baseline varying 
over age, gender, and geographic region. The Stata Software package 11.0 (StataCorp., 2009) 
was used for all calculations and to compute robust confidence intervals, and p-values (by 
applying the Huber–White sandwich matrix) required when basing analyses on weighted data 
(Royall, 1986). Cumulative lifetime status was used in all analyses and created by defining 
caseness as having reported the respective items at any assessment (covering the lifetime 
history up to the age at last assessment). This permitted using information from subjects who 
dropped out of the study during follow-up.  
 
2.3.1. Sequence of and latency between AU/NU and CU initiation. The Kaplan–Meier 
estimator (Therneau and Grambsch, 2000) was used to estimate age-dependent cumulative 
lifetime incidence and timedependent survival rates of substance use.  
 
2.3.2. Risk of any and earlier CU. To investigate associations between covariates of interest 
(younger age at onset of AU and NU (continuous variable, age in years, older age at onset 
compared to younger age at onset), externalizing disorders, parental alcohol or illegal 
substance dependence) and the risk of any and earlier CU, we used logistic and linear 
regression analyses (“crude model”). Multiple logistic and linear regression analyses were 
conducted with all covariates of interest (“multiple model”). Both the “crude” and the 
“multiple” model were additionally adjusted for maximum age as observed until the last 
assessment and gender. Regressions including parental substance dependence were 
additionally adjusted for parental age and information level (three dummy variables for four 
different sources of information about parents; see Section 2.2.2).  
 
2.3.3. Risk of CUD. Cox regressions were applied to assess overall differences in risk of 
transition from first CU to CUD (time scale = years from first CU to CUD) over time as a 
function of the covariates of interest listed above and age at CU onset. Different curves before 
assessing differences according to covariates were allowed for according to year of birth and 
gender (“stratified Cox regression”) (Therneau and Grambsch, 2000). Multiple Cox 
regression analyses were conducted with all covariates of interest and age of CU-onset.  
 
The proportional hazard assumption was tested using Schoenfeld residuals (Therneau and 
Grambsch, 2000). If the assumption was violated, to improve the model fit and to assess how 
strongly the hazard ratios depended on time the interaction term covariate × [number of years 
since first CU] was added to the model. Here, the model-based time-dependent hazard ratio 
equals HR (main effect of covariate) × HR (interaction effect of covariate) number of years. After 
the inclusion of the interaction term the proportional hazard assumption was tested again (in 
the Cox regression as implemented in Stata, cases with CU and CUD onset within the same 
year are excluded. To prevent this, we shifted the time scale for the analysis 1 year upwards, 
replacing 0 years by 1 year, 1 year by 2 years, and so on and afterwards shifted the results 
back by one year.).  
 
For the Cox regression, we used data from subjects with information on age of onset of 
lifetime CU (N = 1343) who were willing to answer drug questions truthfully.  
 
We repeated all analyses with a stricter definition of early substance use experiences. Here, 
we included only cases with AU before NU or no NU (AU-First), respectively only cases with 
NU before AU or no AU (NU-First; AU-First and NU-First refer to mutually exclusive cases. 
Therefore separate multiple models were run for the AU-First and NU-First analyses with age 
of onset of any AU (respectively any NU), externalizing disorders, parental alcohol 
dependence and illegal substance dependence and age at first CU (the latter only in Cox 
regression analysis) as additional covariates.).  
 
Paternal and maternal substance use disorders are considered separately. Because of limited 
power a variable for parental (i.e., paternal and/or maternal) illegal substance dependence was 
used in some analyses, and parental illegal substance dependence was excluded from AU-
First and NU-First multiple logistic regression models.  
 
 
3. Results  
 
3.1. Sequence of and latency between AU/NU and CU initiation  
 
As reported previously (Wittchen et al., 2008), the cumulative incidence rate up to T3 was 
97.7% for AU, 79.2% for NU and 50.7% for CU. The main incidence periods (i.e., the 
steepest increase in the Kaplan–Meier estimates for cumulative lifetime incidence) were ages 
10–16 (AU), 11–17 (NU) and 14–19 (CU).  
 
Almost all subjects with lifetime CU reported lifetime AU (99.6%) and NU (94.7%).  
 
Most (93.0%) users of alcohol and cannabis reported first AU as prior to CU. 4.4% reported 
AU and CU initiation in the same year. 2.5% reported AU as secondary. A comparable 
pattern was found for users of nicotine and cannabis: 87.5% reported primary NU, 8.8% 
initiation in the same year and 3.7% NU as secondary.  
 
In cases in which CU occurred after AU or in the same year, 10% of all transitions from first 
AU to first CU had occurred at one year after first AU (Fig. 1), 20–30% at two years and 
about 40% at three years. The respective proportions were 10–20%, 30–40% and 50% for 
transitions from first NU to first CU.   
 
3.2. The risk of any and early CU and CUD  
 
Younger age at AU-onset (OR: 0.89) and NU-onset (OR: 0.91), paternal (OR: 1.71) and 
maternal alcohol dependence (OR: 1.62) and externalizing disorders (OR: 3.31) were 
associated with a higher risk of any CU (logistic regression results are shown in Table 1).  
 
Younger age at AU- and NU-onset were associated with an average 0.17 (respectively 0.30) 
years younger age at CU-onset. Externalizing disorders and paternal alcohol dependence were 
also associated with earlier CU-onset (linear regression results are shown in Table 2). 
Younger age at AU-onset, paternal alcohol dependence and externalizing disorders were 
associated with a higher risk of CUD (Cox regression results are shown in Table 3). 
Externalizing disorders were marginally associated with a lower speed of transition to CUD 
(hazard ratio (HR) main effect: 1.47; HR interaction effect: 1.12; 95% CI: 1.001–1.26; p = 
0.047).  
 
3.3. Multiple models  
 
In the multiple models, associations with a higher risk of any CU remained significant for 
younger age at AU-onset, externalizing disorders and paternal alcohol dependence (Table 1). 
Younger age at NU-onset, externalizing disorders and paternal alcohol dependence remained 
significant factors for earlier CU-onset (Table 2). Younger age at CU-onset (HR: 0.77), 
externalizing disorders (HR: 1.69) and paternal alcohol dependence (HR: 1.47) were 
associated with a higher CUD-risk. Externalizing disorders were associated with a slower 
transition to CUD (HR main effect: 1.14; HR interaction effect: 1.17; 95% CI: 1.03–1.33; p = 
0.013) (Table 3).  
 
3.4. AU-First and NU-First  
 
Risk of CU: Younger age at onset of AU-First was associated with a higher risk of CU (OR: 
0.82). In the AU-First multiple model, younger age at onset of AU-First, externalizing 
disorders, paternal and maternal alcohol dependence were associated with a higher CU risk as 
were younger age at AU-onset and externalizing disorders in the NU-First multiple model 
(Table 1).  
 
Earlier CU-onset: Younger age at onset of AU-First and NU-First were associated with an 
average 0.26 (0.14) years younger age of CU-onset, but only in the crude model (Table 2).  
 
Risk of CUD: Younger age at AU-First onset was associated with a higher CUD risk (HR: 
0.88). In the AU-First multiple model only younger age at CU-onset was associated with a 
higher risk of CUD. In the NU-First multiple model younger age at CU-onset and maternal 
alcohol dependence were associated with higher CUD risk (Table 3).  
 
 
4. Discussion  
 
We investigated the cross-substance relationship between, respectively a younger age at onset 
of alcohol use and a younger age at onset of nicotine use and the risk of cannabis use 
disorders, taking into account age of cannabis use onset, externalizing disorders, and parental 
substance use disorders as important influential factors for the risk of cannabis use and 
disorders. The main findings are: (1) Almost all cannabis users had prior experience with 
alcohol (99.6%) and nicotine (94.7%) use. Cannabis use almost invariably occurred after first 
alcohol and first nicotine use. (2) After adjustment for externalizing disorders and parental 
substance dependence, a younger age at first alcohol use was associated with a higher risk of 
any cannabis use; a younger age at first nicotine use with a younger age at first cannabis use. 
(3) Younger age at first alcohol and nicotine use was not associated with the risk of cannabis 
use disorders after adjustment for externalizing disorders, early onset of cannabis use and 
parental substance dependence. (4) Overall, taking into account the temporal order of onset of 
alcohol and nicotine use did not produce more consistent associations with the risk of 
cannabis use and disorders.  
 
In western societies, substance use almost normatively begins with alcohol or nicotine use. 
Typically, the main incidence phases for alcohol and nicotine use occur earlier than the main 
incidence phase for cannabis use (Degenhardt et al., 2009; Kandel and Yamaguchi, 1993; 
Wagner and Anthony, 2002a; Wittchen et al., 2008; Young et al., 2002). Our findings agree 
with this evidence. However, here and in other studies (Degenhardt et al., 2009), the sequence 
pattern for nicotine and cannabis was less distinct than for alcohol and cannabis (e.g., larger 
proportion of cannabis use initiation before nicotine use). Still, the sequence-pattern suggests 
that alcohol and nicotine use may play a role for cannabis effects and for developing cannabis 
use disorders for example via cross-tolerance or cross-sensitivity (Perkins et al., 2009). Here, 
40–50% of cannabis use-onsets occurred within three years after initial alcohol/nicotine use. 
For this considerable proportion of subjects, the time-window for efforts to prevent multiple 
substance use (Pape et al., 2009) and its potential sequelae is relatively narrow.  
 
To our knowledge it is, to date, unclear whether a cross-substance relationship exists between 
younger age at first alcohol and nicotine use and the risk of cannabis use disorders and 
whether this relationship is independent of important factors as externalizing disorders, early 
cannabis use onset and parental substance dependence. Our study adds to current knowledge 
by showing that with few exceptions, younger age at first alcohol use and at first nicotine use 
were associated with the risk of (early) cannabis use and cannabis use disorders. However, 
importantly, most of these cross-substance associations were attenuated after adjustment for 
externalizing disorders and parental substance dependence. In the associations that remained 
significant, specific factors related to younger age at first alcohol or nicotine use may be 
influential as discussed below. However, these factors may only influence cannabis use; we 
found no evidence for a role of younger age at first alcohol or nicotine use in the risk of 
cannabis use disorders after adjustment for the abovementioned factors.  
 
4.1. Risk of any cannabis use  
 
Here, a younger age at first alcohol use was associated with an increased risk of cannabis use, 
independent of externalizing disorders and parental substance dependence. A younger age at 
first nicotine use was also associated with a higher risk of cannabis use, but not after 
adjustment for externalizing disorders and parental substance dependence. In conclusion, 
early alcohol use initiation is a risk factor not only for alcohol dependence (DeWit et al., 
2000; Ellickson et al., 2004; Sartor et al., 2009) but also for cannabis use. A specific factor in 
this relationship may be that a younger age at first alcohol use is associated with heavy 
drinking (Buchmann et al., 2009). One may speculate that subjects with heavy drinking 
experience may intend to experience intoxication related to another substance and therefore 
try cannabis.  
 
4.2. Risk of younger age at cannabis use onset  
 
We extend earlier findings (Kokkevi et al., 2006) by showing that a younger age at first 
alcohol use and a younger age at first nicotine use were associated with a younger age at first 
cannabis use. For younger age at first nicotine use the association was independent of 
externalizing disorders and parental substance dependence, suggesting that younger age at 
onset of nicotine use is a risk factor for earlier cannabis use initiation. Thus, importantly, 
while no direct association between earlier onset of nicotine use and cannabis use disorders 
was found, earlier nicotine use may indeed be of indirect relevance for cannabis use disorder 
risk via earlier onset of cannabis use, which is a risk factor for cannabis use disorders (Chen et 
al., 2005). Still, it has to be noted that the average difference in age at first cannabis use by 
earlier smoking onset (0.2 years) found here may be too small to play a role in cannabis use 
disorder development. Younger age at first alcohol use was not associated with a younger age 
at first cannabis use after adjustment for parental alcohol dependence, for example. Paternal 
alcohol dependence is related to younger age at onset of both alcohol and cannabis use (Obot 
et al., 2001). Also, a considerable overlap of genetic factors exists for age at first alcohol and 
age at first cannabis use. This overlap is smaller for nicotine and cannabis (Sartor et al., 
2009).  
 
The differences in findings for younger age at alcohol and nicotine use may indicate that in 
addition to a general vulnerability for early substance use (McGue and Iacono, 2008), specific 
risk factors may be important for early onset of use of different substances.   
 
4.3. Risk of cannabis use disorders  
 
Our study adds to current knowledge by showing that a younger age at first alcohol use is 
associated with a higher risk of cannabis use disorders. However, against our expectation, this 
association was non-significant after adjustment for important covariates (externalizing 
disorders, early cannabis use onset and parental substance dependence). Thus, the relevance 
of a younger age at first alcohol and nicotine use was limited to any cannabis use, respectively 
especially early cannabis use initiation. In contrast, younger age at first cannabis use, paternal 
alcohol dependence and externalizing disorders were consistently associated with cannabis 
use and disorders. This probably confirms the importance of these factors as more general risk 
factors for early substance use and substance use disorders (Elkins et al., 2007; Hayatbakhsh 
et al., 2008; King et al., 2004; Obot et al., 2001). The findings on younger age at first cannabis 
use may underline the importance of substance-specific associations between younger age at 
first use and the risk of a substance use disorder (Agrawal et al., 2009; Buchmann et al., 2009; 
Dawson et al., 2008). Differential sensitivity to cannabis effects in adolescence may be of 
importance in this relationship for cannabis (Schramm-Sapyta et al., 2009). For example, 
animal studies suggest less acute aversive effects of cannabis in adolescence (Quinn et al., 
2008; Schramm-Sapyta et al., 2007) as well as impairment of working memory and (non-) 
spatial learning after cannabis exposure (Cha et al., 2006; O’Shea et al., 2004; Quinn et al., 
2008). Cannabis exposure in adolescence may also alter the development of the 
endocannabinoid system (Malone et al., 2010). In early cannabis users, these factors may 
contribute to the more intense cannabis use necessary for cannabis use disorder development.  
 
While certain sequences of substance use initiation can be related to dependence risk 
(Degenhardt et al., 2009) our results do not suggest that the sequence of alcohol and nicotine 
use initiation plays a role in the risk of cannabis use and disorders. The primacy of alcohol use 
with respect to nicotine use may not represent a deviant initiation pattern associated with 
further problematic development.  
 
In conclusion, our results do not suggest a direct cross-substance momentum of younger age 
at first alcohol and nicotine use for the risk of cannabis use disorders but underline the 
importance of younger age at first cannabis use as a substance-specific factor, externalizing 
disorders and paternal alcohol dependence in this regard. Still, importantly, younger age at 
first nicotine use may be of indirect relevance for the risk of cannabis use disorders. Also, 
younger age at first alcohol use was related to any cannabis use independent of externalizing 
disorders and familial substance dependence. Delaying first alcohol use may serve to prevent 
any cannabis use while delaying first nicotine use may serve to prevent especially early 
cannabis use and thus even help reducing the risk of cannabis use disorders.  
 
4.4. Limitations  
 
We used age of onset information that may underlie recall bias. Aggregation of data over the 
assessment waves was necessary because of restricted power. Therefore, the temporal order 
for covariates and outcomes was not established. However, the sequence of initiation shows 
that initial cannabis use mostly occurs after initial alcohol and nicotine use. Parental 
diagnoses were partially based on FH-information. However, direct information was used 
whenever possible. Also, agreement between FH and direct information on alcohol 
dependence is at least fair (Vandeleur et al., 2008).  
 
4.5. Future research  
 
As most cannabis users also use alcohol and nicotine, mostly prior to cannabis, future 
research should investigate crosstolerance and -sensitivity for these three substances in 
adolescents to further clarify the role of alcohol and nicotine use for cannabis use 
development. To further improve knowledge on the role of early substance use as a risk factor 
for substance use disorders, the limitation of the role of younger age at first alcohol and 
nicotine use to early stages of cannabis involvement should be investigated.  
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